ArticleNPJ precision oncology2017
Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems.
Samir V Jenkins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this paperpooled itcites it